Log in

NYSE:CTVACorteva Stock Price, Forecast & News

$27.31
+0.32 (+1.19 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$26.71
Now: $27.31
$27.43
50-Day Range
$22.77
MA: $25.40
$27.93
52-Week Range
$20.38
Now: $27.31
$32.78
Volume6.29 million shs
Average Volume4.35 million shs
Market Capitalization$20.44 billion
P/E RatioN/A
Dividend Yield1.90%
BetaN/A
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.20 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
SectorConsumer Staples
CUSIPN/A
CIKN/A
Phone302-485-3000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.85 billion
Cash Flow$5.40 per share
Book Value$32.81 per share

Profitability

Net Income$-959,000,000.00

Miscellaneous

EmployeesN/A
Market Cap$20.44 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive CTVA News and Ratings via Email

Sign-up to receive the latest news and ratings for CTVA and its competitors with MarketBeat's FREE daily newsletter.

Corteva (NYSE:CTVA) Frequently Asked Questions

How has Corteva's stock been impacted by COVID-19 (Coronavirus)?

Corteva's stock was trading at $25.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CTVA shares have increased by 9.2% and is now trading at $27.31. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Corteva?

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There are currently 1 sell rating, 13 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Corteva.

When is Corteva's next earnings date?

Corteva is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Corteva.

How were Corteva's earnings last quarter?

Corteva (NYSE:CTVA) released its quarterly earnings data on Wednesday, May, 6th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.20. The company earned $3.96 billion during the quarter, compared to analysts' expectations of $3.56 billion. Corteva had a positive return on equity of 5.09% and a negative net margin of 5.91%. The business's quarterly revenue was up 16.5% on a year-over-year basis. View Corteva's earnings history.

How often does Corteva pay dividends? What is the dividend yield for Corteva?

Corteva declared a quarterly dividend on Tuesday, April 28th. Shareholders of record on Friday, May 15th will be paid a dividend of $0.13 per share on Monday, June 15th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date is Thursday, May 14th. View Corteva's dividend history.

What price target have analysts set for CTVA?

26 brokerages have issued 12 month target prices for Corteva's stock. Their forecasts range from $24.00 to $39.00. On average, they anticipate Corteva's stock price to reach $30.47 in the next year. This suggests a possible upside of 11.6% from the stock's current price. View analysts' price targets for Corteva.

Has Corteva been receiving favorable news coverage?

Media coverage about CTVA stock has trended very positive recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Corteva earned a news impact score of 3.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutCorteva.

Are investors shorting Corteva?

Corteva saw a increase in short interest in May. As of May 15th, there was short interest totaling 10,680,000 shares, an increase of 19.7% from the April 30th total of 8,920,000 shares. Based on an average daily trading volume, of 5,080,000 shares, the short-interest ratio is currently 2.1 days. Approximately 1.4% of the shares of the stock are short sold. View Corteva's Current Options Chain.

Who are some of Corteva's key competitors?

What other stocks do shareholders of Corteva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corteva investors own include Dow Chemical (DOW), Cisco Systems (CSCO), AT&T (T), CVS Health (CVS), Verizon Communications (VZ), E I Du Pont De Nemours And Co (DD), Home Depot (HD), Johnson & Johnson (JNJ), NVIDIA (NVDA) and Walt Disney (DIS).

What is Corteva's stock symbol?

Corteva trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTVA."

Who are Corteva's major shareholders?

Corteva's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.78%), State Street Corp (5.70%), Aristotle Capital Management LLC (3.33%), Invesco Ltd. (2.99%), Geode Capital Management LLC (1.63%) and Capital World Investors (1.54%). Company insiders that own Corteva stock include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel and Timothy P Glenn. View institutional ownership trends for Corteva.

Which institutional investors are selling Corteva stock?

CTVA stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, JPMorgan Chase & Co., Mackenzie Financial Corp, Nuveen Asset Management LLC, State Street Corp, Clearbridge Investments LLC, TCW Group Inc., and Confluence Investment Management LLC. View insider buying and selling activity for Corteva.

Which institutional investors are buying Corteva stock?

CTVA stock was purchased by a variety of institutional investors in the last quarter, including Aristotle Capital Management LLC, Van ECK Associates Corp, Janus Henderson Group PLC, Principal Financial Group Inc., Factory Mutual Insurance Co., 1832 Asset Management L.P., Swiss National Bank, and Invesco Ltd.. Company insiders that have bought Corteva stock in the last two years include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel, and Timothy P Glenn. View insider buying and selling activity for Corteva.

How do I buy shares of Corteva?

Shares of CTVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Corteva's stock price today?

One share of CTVA stock can currently be purchased for approximately $27.31.

How big of a company is Corteva?

Corteva has a market capitalization of $20.44 billion and generates $13.85 billion in revenue each year. The company earns $-959,000,000.00 in net income (profit) each year or $1.43 on an earnings per share basis.

What is Corteva's official website?

The official website for Corteva is www.corteva.com.

How can I contact Corteva?

Corteva's mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company can be reached via phone at 302-485-3000.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.